VBI Vaccines Valuation
Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. VBI Vaccines current Real Value cannot be determined due to lack of data. The regular price of VBI Vaccines is $0.0. Our model measures the value of VBI Vaccines from examining the entity fundamentals such as Return On Asset of -0.29, shares outstanding of 28.68 M, and Return On Equity of -4.2 as well as evaluating its technical indicators and probability of bankruptcy.
VBI Vaccines Total Value Analysis
VBI Vaccines is at this time forecasted to have valuation of 38.92 M with market capitalization of 1.87 M, debt of 53.04 M, and cash on hands of 82.41 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the VBI Vaccines fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
38.92 M | 1.87 M | 53.04 M | 82.41 M |
VBI Vaccines Investor Information
The company has Price to Book (P/B) ratio of 1.24. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. VBI Vaccines recorded a loss per share of 3.54. The entity last dividend was issued on the 28th of December 2012. The firm had 1:30 split on the 12th of April 2023. Based on the key indicators related to VBI Vaccines' liquidity, profitability, solvency, and operating efficiency, VBI Vaccines is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.VBI Vaccines Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. VBI Vaccines has an asset utilization ratio of 9.98 percent. This indicates that the Company is making $0.0998 for each dollar of assets. An increasing asset utilization means that VBI Vaccines is more efficient with each dollar of assets it utilizes for everyday operations.VBI Vaccines Ownership Allocation
VBI Vaccines shows a total of 28.68 Million outstanding shares. VBI Vaccines has 6.76 % of its outstanding shares held by insiders and 13.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the entity is less than the current market value, you may not be able to make money on it.VBI Vaccines Profitability Analysis
The company reported the previous year's revenue of 8.68 M. Net Loss for the year was (92.84 M) with loss before overhead, payroll, taxes, and interest of (10.19 M).VBI Vaccines Growth Indicators
Investing in growth stocks can be very risky. If the company such as VBI Vaccines does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 15.6 M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in VBI Stock
If you are still planning to invest in VBI Vaccines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the VBI Vaccines' history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Global Correlations Find global opportunities by holding instruments from different markets |